Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Psychosis Social Cognition Training With Oxytocin
ACTRN12612000190808Phase 2Completed
- Sponsor
- The University of Sydney
- Start
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Schizophrenia Spectrum and Other Psychotic Disorders (SZ) and psychosis comparing SCT + oxytocin + TAU with SCT + placebo nasal spray + TAU (2 arms). Primary endpoints: Change in social cognition, Change in social function and 1 more. Started Jan 2012; status: completed.
02
Drugs
oxytocin
03
Conditions
Schizophrenia Spectrum and Other Psychotic Disorders (SZ)psychosis
Beyond the preview
Go deeper on ACTRN12612000190808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000190808.